Aravive, Inc. Uncategorized Contracts & Agreements

44 Contracts & Agreements
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Offer Letter, dated April 10, 2023, by and between Aravive, Inc. and Maria Carolina Petrini
Aravive, Inc.
Biotechnology
DE
2023
Description of Capital Securities
Aravive, Inc.
Biotechnology
2023
Amendment No. 1 to Offer Letter dated as of February 1, 2023 by and between Aravive, Inc. and Leonard Scott Dove, Ph.D
Aravive, Inc.
Biotechnology
2023
Amendment No. 1 to Offer Letter dated as of February 1, 2023 by and between Aravive, Inc. and Robert Geller, M.D
Aravive, Inc.
Biotechnology
2023
Amendment No. 1 to Offer Letter dated as of February 1, 2023 by and between Aravive, Inc. and RudyHoward
Aravive, Inc.
Biotechnology
2023
Amendment No. 3 to Offer Letter dated as of February 1, 2023 by and between Aravive, Inc. and Gail McIntyre, Ph.D
Aravive, Inc.
Biotechnology
2023
Form of Side Letter Agreement by and among Aravive, Inc. and the BVF Investor party thereto
Aravive, Inc.
Biotechnology
NY
2022
Form of Side Letter Agreement by and among Aravive, Inc. and the persons party thereto
Aravive, Inc.
Biotechnology
NY
2022
Offer Letter, dated June 13, 2022, by and between Aravive, Inc. and Dr. Robert B. Geller
Aravive, Inc.
Biotechnology
DE
2022
Offer Letter, dated June 2, 2022, by and between Aravive, Inc. and Rudy C. Howard
Aravive, Inc.
Biotechnology
DE
2022
Offer Letter between Leonard Scott Dove, Ph.D. and Aravive, Inc
Aravive, Inc.
Biotechnology
DE
2022
Offer Letter, dated September 8, 2020 between Reshma Rangwala and the Company
Aravive, Inc.
Biotechnology
DE
2021
Description of Capital Securities
Aravive, Inc.
Biotechnology
2021
Amendment to Offer Letter dated as of January 25, 2021 by and between Aravive, Inc. and Gail McIntyre, Ph.D
Aravive, Inc.
Biotechnology
2021
Amendment to Offer Letter dated as of April 8, 2020 by and between the Company and Gail McIntyre
Aravive, Inc.
Biotechnology
2020
Option Agreement dated April 8, 2020 by and between the Company and Robert Hoffman
Aravive, Inc.
Biotechnology
DE
2020
Option Agreement dated April 8, 2020 by and between the Company and Jay Shepard
Aravive, Inc.
Biotechnology
DE
2020
Option Agreement dated April 8, 2020 by and between the Company and Srini Akkaraju
Aravive, Inc.
Biotechnology
DE
2020
Offer Letter, dated March 26, 2020 between Gail McIntyre and Aravive, Inc
Aravive, Inc.
Biotechnology
CA
2020
Offer Letter, dated March 26, 2020, between Vinay Shah and Aravive, Inc
Aravive, Inc.
Biotechnology
CA
2020
Description of Capital Securities
Aravive, Inc.
Biotechnology
2020
Offer Letter, dated January 8, 2020, between Rekha Hemrajani and Aravive, Inc
Aravive, Inc.
Biotechnology
CA
2020
Amendment to Jay Shepard Offer Letter dated as of February 28, 2019
Aravive, Inc.
Biotechnology
2019
Offer Letter dated January 1, 2017 by and between Aravive Biologics, Inc. and Gail McIntyre
Aravive, Inc.
Biotechnology
2019
Offer Letter dated February 1, 2017 and the amendment thereto dated May 30, 2018 by and between Aravive Biologics, Inc. and Vinay Shah
Aravive, Inc.
Biotechnology
2019
Amendment to Jay Shepard Offer Letter dated as of February 6, 2019
Aravive, Inc.
Biotechnology
2019
Cancer Research Grant Contract, dated December 1, 2015, by and between the Cancer Prevention and Research Institute of Texas and Ruga Corporation
Aravive, Inc.
Biotechnology
TX
2018
Form of Support Agreement, by and between Aravive Biologics, Inc. and Versartis, Inc.s directors, officers and certain stockholders
Aravive, Inc.
Biotechnology
DE
2018
Form of Support Agreement, by and between Versartis, Inc. and Aravive Biologics, Inc.s directors, officers and certain stockholders
Aravive, Inc.
Biotechnology
DE
2018
Offer Letter with Robert Gut, dated August 30, 2017
Aravive, Inc.
Biotechnology
CA
2018
AMUNIX OPERATING INC. 500 Ellis Street Mountain View, CA 94043
Aravive, Inc.
Biotechnology
2017
Versartis, Inc. 4200 Bohannon Drive, Suite 250 Menlo Park, CA 94025 02/16/2016
Aravive, Inc.
Biotechnology
CA
2016
Versartis, Inc. 4200 Bohannon Drive, Suite 250 Menlo Park, CA 94025 02/27/2015
Aravive, Inc.
Biotechnology
CA
2016
Versartis, Inc. 4200 Bohannon Drive, Suite 250 Menlo Park, CA 94025 May 12, 2015
Aravive, Inc.
Biotechnology
CA
2015
4200 Bohannon Drive, Suite 250 | Menlo Park, CA 94025 | 650 ###-###-#### (main)
Aravive, Inc.
Biotechnology
CA
2015
TECHNOLOGY TRANSFER AND CLINICAL SUPPLYAGREEMENT
Aravive, Inc.
Biotechnology
2014
AMENDMENT NO. 2 TO SECOND AMENDED AND RESTATED LICENSING AGREEMENT
Aravive, Inc.
Biotechnology
CA
2014
VERSARTIS, INC. 500 ELLIS STREET MOUNTAIN VIEW, CA 94043 February 10, 2011
Aravive, Inc.
Biotechnology
CA
2014
VERSARTIS, INC. 275 SHORELINE DRIVE, SUITE 450 REDWOOD CITY, CA 94065 November 8, 2013
Aravive, Inc.
Biotechnology
CA
2014
VERSARTIS, INC. December 20, 2010
Aravive, Inc.
Biotechnology
CA
2014